WNT11 and Alzheimer disease: These data prompted us to suggest that S-nitrosylation of the components of the WNT signaling pathway, such as WNT11 and Frizzled10, mediates dysregulation of this pathway resulting in altered mTOR signaling, which in turn contributes to AD pathology.